Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -6 of 6
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
A Pharmacokinetic Study of Actinomycin-D and Vincristine in Children With Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Biomarker/Laboratory analysis, Treatment
Active
18 and under
NICHD
PPRU 10762
NCT00491946
Last Modified:
10/6/2008
 
First Published:
8/18/2006
2.
Phase III Randomized Study of Glutamic Acid in Reducing Vincristine-Related Peripheral Neurotoxicity in Young Patients Undergoing Vincristine-Containing Treatment for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphoblastic Leukemia, or Non-Hodgkin's Lymphoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care, Treatment
Active
3 to 20
NCI
MCC-0402
NCT00369564, ACCL 0731
Last Modified:
9/29/2008
 
First Published:
7/7/2006
3.
Phase III Study of Adjuvant Vincristine and Dactinomycin With or Without Doxorubicin Hydrochloride and Radiotherapy or Observation Only in Younger Patients Who are Undergoing Nephrectomy for Newly Diagnosed Stage I-III Favorable Histology Wilms' Tumor
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
Under 30 at diagnosis
NCI
COG-AREN0532
AREN0532, NCT00352534
Last Modified:
6/6/2008
 
First Published:
6/2/2006
4.
Phase II Study of Combination Chemotherapy, Radiotherapy, and/or Surgery in Patients With High-Risk Renal Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
30 and under
NCI
COG-AREN0321
AREN0321, NCT00335556
5.
Topotecan, Ifosfamide and Carboplatin in Children and Young Adults With Solid Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Active
45 and under
Other
2004-0079
NCT00502892
6.
Respiratory Tumor and Normal Tissue Motion
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Natural history/Epidemiology, Treatment
Active
Not specified
Other
2003-0962
NCT00415675
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute